KindlyMD(TM) Collaborates with Curaleaf to Expand Patient Education on Medical Cannabis Care in Utah
Community care events to be held throughout summer at Curaleaf's Lehi, Provo, and Payson, Utah Medical Cannabis Pharmacies SALT LAKE...
Addiction
Parents Gather in Washington, DC to Support McCourt-led People’s Bid for TikTok
Leaders of parents' groups from across the country share their personal experiences with the harmful impact of Big Tech on...
Lifeskills South Florida Expands Mental Health and Addiction Treatment Services to Orlando, Florida
BRENTWOOD, TN / ACCESSWIRE / June 6, 2024 / Odyssey Behavioral Healthcare, a leading provider of mental health, addiction, and...
STR Behavioral Health Opens New Cedar Creek Campus Providing Mental Health Residential Services in Pennsylvania
BRENTWOOD, TN / ACCESSWIRE / June 5, 2024 / Odyssey Behavioral Healthcare, a leading provider of addiction, mental health, and...
Masimo Joins Forces with the Mobilize Recovery 2024 Bus Tour
Collaborative Partnership Designed to Enhance Nationwide Efforts to Combat the Opioid Epidemic and Improve Addiction RecoveryIRVINE, Calif.--(BUSINESS WIRE)--Masimo (NASDAQ: MASI),...
KindlyMD Becomes First Utah Alternative Medical Treatment Company to Contract Under State’s Top Insurance Payors
Insurance payors include Medicare, Utah's largest insurer, Select Health, and Medicaid, providing KindlyMD nearly 70% statewide comprehensive insurance coverage SALT...
Adial Pharmaceuticals Achieves Important Milestone of First Patient Dosed in Pharmacokinetics Study of AD04 for the Treatment of Alcohol Use Disorder
Study intended to optimize design elements needed for the upcoming US Pivotal Phase 3 studiesand support ongoing partnership discussions Topline...
Newport Healthcare Leaders to Present Today at NAMICon, the Annual Conference of the National Alliance on Mental Illness
Thought Leaders Barbara Nosal, PhD, LMFT, LADC, and Don Grant, PhD, MA, MFA, DAC, SUDCC IV, to Address the Impact...
KindlyMD to Present at the KCSA Cannabis Virtual Investor Conference on June 5th
SALT LAKE CITY, UT / ACCESSWIRE / June 4, 2024 / KindlyMD, Inc. (NASDAQ:KDLY)(NASDAQ:KDLYW) ("KindlyMD" or "the Company"), a patient-first...
KindlyMD Announces Closing of $6.8 Million Initial Public Offering
SALT LAKE CITY, UT / ACCESSWIRE / June 3, 2024 / KindlyMD, Inc. (NASDAQ:KDLY)(NASDAQ:KDLYW) ("KindlyMD" or the "Company"), a patient-first...
KindlyMD Announces Pricing of $6.8 Million Initial Public Offering
SALT LAKE CITY, UT / ACCESSWIRE / May 31, 2024 / KindlyMD, Inc. (NASDAQ:KDLY)(NASDAQ:KDLYW) ("KindlyMD" or the "Company"), a patient-first...
atai Life Sciences to Participate in the Jefferies 2024 Global Healthcare Conference
NEW YORK and BERLIN, May 31, 2024 (GLOBE NEWSWIRE) -- atai Life Sciences (NASDAQ: ATAI) (“atai” or “Company”), a clinical-stage biopharmaceutical...
Safe Supply Streaming Corp. Announces Strategic Expansion into AI-Powered Healthcare Solutions
Toronto, Ontario--(Newsfile Corp. - May 30, 2024) - Safe Supply Streaming Co Ltd. (CSE: SPLY) (FSE: QM4) (OTCQB: SSPLF) ("Safe...
Lifeguard Digital Health Announces 100 Lives Saved Through Its Overdose Prevention Apps
The LifeguardLite™ and LifeguardConnect™ Apps from Lifeguard Digital Health are saving lives during the opioid crisis.VANCOUVER, British Columbia--(BUSINESS WIRE)--Lifeguard Digital...
Adial CEO to Present at the Spring MicroCap Rodeo Conference on June 6th
GLEN ALLEN, Va., May 29, 2024 (GLOBE NEWSWIRE) -- Adial Pharmaceuticals, Inc. (NASDAQ: ADIL) (“Adial” or the “Company”), a clinical-stage...
Rehab.com Study Finds Southern States Rank Worst in Nation for Drug Abuse & Addiction
NEW YORK, NY / ACCESSWIRE / May 28, 2024 / Five Southern states rank as the worst in the nation...
Laguna Treatment Center Unveils New Name and Expanded Mission with Ribbon-Cutting Ceremony
Laguna Treatment Center Ribbon-Cutting Laguna Treatment Center Ribbon-Cutting ALISO VIEJO, Calif., May 24, 2024 (GLOBE NEWSWIRE) -- Laguna Treatment Center,...
Hydreight Technologies through its associated Medical network now offer Tirzepatide to Product Offering which also features GLP-1 Medications (Low-Cost Semaglutide), NAD+ and more
Tirzepatide, a dual GIP and GLP-1 receptor agonist (GIP/GLP-1 RA), is an antidiabetic medication used for the treatment of type...
atai Life Sciences Strengthens Board with Appointment of Two New Independent Directors
NEW YORK and BERLIN, May 23, 2024 (GLOBE NEWSWIRE) -- atai Life Sciences (NASDAQ: ATAI) (“atai” or “Company”), a clinical-stage biopharmaceutical...
Achieve Life Sciences Announces Data from Cytisinicline ORCA-V1 Program to be Presented at Society of General Internal Medicine (SGIM) Annual Meeting
SEATTLE and VANCOUVER, British Columbia, May 17, 2024 (GLOBE NEWSWIRE) -- Achieve Life Sciences, Inc. (Nasdaq: ACHV), a late-stage pharmaceutical...